BSF Enterprise PLCLSE: BSFA

BSF Enterprise: Conversion of Convertible Loan Notes

· Issued by BSF Enterprise PLC

Summary by 6ix AI

BSF Enterprise PLC, a biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, received a notice from Indigo Capital Investments (Indigo) to convert £100,283 of the £1m outstanding under its convertible loan note instrument, and will issue 10,000,000 new ordinary shares of 1 penny each to Indigo in satisfaction of that amount.

Key details

  • A convertible loan note is a loan that the lender can turn into shares of the borrower instead of being repaid in cash.
  • The new shares will rank equally in all respects with BSF's existing ordinary shares.
  • Following admission of the new shares, BSF's issued share capital and total voting rights will comprise 203,749,437 ordinary shares.
  • BSF said the announcement contains inside information under the UK market abuse rules.

What’s still pending

  • Application will be made for the new shares to be admitted to the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities.
  • Admission and dealings in the new shares are expected to begin at 8.00 a.m. on August 28, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

25 August 2026

BSF Enterprise PLC

("BSF" or the "Company")

Conversion of Convertible Loan Notes

BSF Enterprise Plc (LSE: BSFA), (OTCQB: BSFAF), the biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, announces that it has received a notice from Indigo Capital Investments ("Indigo") to convert £100,283 of the outstanding amount of £1m under the Company's convertible loan note instrument (the "CLN").

Accordingly, the Company will issue 10,000,000 new ordinary shares of 1 penny each to Indigo (the "Conversion Shares") in satisfaction of £100,283 of the outstanding amount under the CLN.

Admission and Total Voting Rights

Application will be made for the Conversion Shares to be admitted to the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). Admission is expected to become effective and dealings in the Conversion Shares to commence at 8.00 a.m. on 28 August 2026.

The Conversion Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Following Admission, the Company's issued share capital and total voting rights will comprise 203,749,437 ordinary shares.

This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

Navigate to our Interactive Investor website here: https://bsfenterprise.com/link/r6w2wP

For further enquiries, please visit www.bsfenterprise.com or contact:

BSF Enterprise PLC

Geoff Baker - Chairman

Che Connon - CEO & Director

We encourage all investors to share questions on this announcement via our investor website.

Bowsprit Partners

John Treacy

James Sheehan

+44 (0)203 883 4430

ISIN of the Ordinary Shares

is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

BSF Enterprise PLC on 6ix

Story so far

Earlier from BSF Enterprise

Later from BSF Enterprise

All BSF Enterprise news releases